Printer Friendly

Articles from M2 Pharma (September 25, 2018)

1-24 out of 24 article(s)
Title Author Type Words
Alexion Touts Phase 3 PREVENT Study of Soliris in Patients with Neuromyelitis Optica Spectrum Disorder. 366
Anaeropharma Science enters into Bifidobacterium collaborative research agreement with Astellas. 190
AstraZeneca reports positive result for Farxiga in DECLARE-TIMI 58 trial. Financial report 328
AstraZeneca's Imfinzi receives marketing authorisation in EU for stage III NSCLC. 223
Atox Bio to continue pre-planned safety review of ACCUTE trial of Reltecimod for treating Necrotizing Soft Tissue Infections upon DMC's recommendation. 310
Boston Scientific wins US FDA approval for Eluvia Drug-Eluting Vascular Stent System for treating patients with peripheral artery disease. 273
Cerveau Technologies Inks Research Agreement with Ionis Pharmaceuticals for Novel Tau Imaging Agent. 172
CHMD grants GlaxoSmithKline and Innoviva approval for the expanded use of Trelegy Ellipta. 221
Farxiga Achieved a Positive Result in the Phase III DECLARE-TIMI 58 Trial, a Large Cardiovascular Outcomes Trial in 17,000 Patients with Type 2 Diabetes, According to AstraZeneca. 398
GeneCentric Therapeutics Licenses Pancreatic Cancer Subtyping Technology from University of North Carolina. 490
Genentech's Investigational Medicine Entrectinib Showed a Durable Response of More Than Two Years in People with a Specific Type of Lung Cancer. 708
Genentech's Tecentriq in Combination with Pemetrexed and Platinum-Based Chemotherapy Reduced the Risk of Disease Worsening or Death in a Type of Previously Untreated Advanced Lung Cancer. 140
Gilead Subsidiary to Launch Authorized Generics of Epclusa and Harvoni for the Treatment of Chronic Hepatitis C. 372
Holmusk announces USD9.75m from Pre-Series A financing. 162
Immunexpress Inc announces patent allowances in the US & EU to support gene expression technology in differentiating SIRS & sepsis. 220
Ionis Pharmaceuticals names new directors. 296
Lonza adds two new Ibex solutions offerings to biopark in Switzerland. 221
Mitsubishi Tanabe Pharma America names Joseph Scalia as VP of Sales and Marketing. 134
Mitsubishi Tanabe Pharma America names new vice president of Commercial Sales and Marketing. 213
New Study Reveals the Importance of Active-DHA in the Developing Brain. 430
Novartis reveals plans to file ex-US for new indication for Lucentis. 201
Synergy Pharmaceuticals Strengthens Coverage for Trulance with New US Market Access Wins. 743
The US Food and Drug Administration Lifts Partial Clinical Hold on Tazemetostat Clinical Programme. 397
UPMC Health Plan wins USD6.3m PCORI research contract. 273

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters